Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

Clinical trial NCT00480324 · COMPLETED

Trial details

NCT number: NCT00480324
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Rotavirus Rotavirus Vaccines

Start date: 2007-06-19
Primary completion: 2009-03-31
Enrollment: 765

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.